BDTX
Black Diamond Therapeutics Inc
1.80$
-7.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.0% | -10.1% | +5.2% | -8.1% | -11.1% | +43.7% | -5.6% | -5.2% | -9.3% | -7.1% | -5.9% | |
| – | -8.9% | -11.4% | +6.7% | -8.8% | -12.4% | +53.9% | -5.8% | -5.3% | -4.7% | -7.2% | -6.2% | |
| – | -3.0% | -54.8% | +29.1% | -28.6% | +55.5% | +170.1% | -69.5% | +2.9% | -32.0% | +43.3% | -36.2% | |
| – | -8.9% | -12.3% | +6.7% | -8.4% | -12.5% | +54.6% | -6.3% | -5.1% | -5.1% | -8.1% | -6.6% | |
| – | +9.9% | -8.6% | +2.0% | +3.9% | -2.8% | -11.8% | -2.7% | -6.5% | -2.5% | -7.1% | +1.1% | |
| – | +30.4% | -14.2% | +9.4% | +12.8% | -1.1% | -18.1% | -0.2% | -7.5% | +1.2% | -7.6% | +9.0% | |
| – | +2.3% | +2.3% | +2.3% | +2.2% | +2.3% | +8.8% | +2.1% | -3.9% | +2.2% | +2.2% | +2.1% | |
| – | +234.9% | -49.4% | -35.1% | +158.3% | +103.3% | -34.4% | -70.7% | +26.5% | -40.6% | +412.8% | -52.7% | |
| – | -13.1% | -10.6% | +6.4% | -12.2% | -14.5% | +69.9% | -6.3% | -4.9% | -11.1% | -7.1% | -7.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -6.9% | +9.2% | +6.5% | +2.5% | +0.2% | +1.9% | -1.5% | +0.2% | +0.3% | +0.2% | +0.2% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.